The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia Guidelines

   


Authors: Boyiadzis, M. M.; Aksentijevich, I.; Arber, D. A.; Barrett, J.; Brentjens, R. J.; Brufsky, J.; Cortes, J.; De Lima, M.; Forman, S. J.; Fuchs, E. J.; Fukas, L. J.; Gore, S. D.; Litzow, M. R.; Miller, J. S.; Pagel, J. M.; Waller, E. K.; Tallman, M. S.
Title: The Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of acute leukemia
Abstract: Acute leukemia is a constellation of rapidly progressing diseases that affect a wide range of patients regardless of age or gender. Traditional treatment options for patients with acute leukemia include chemotherapy and hematopoietic cell transplantation. The advent of cancer immunotherapy has had a significant impact on acute leukemia treatment. Novel immunotherapeutic agents including antibody-drug conjugates, bispecific T cell engagers, and chimeric antigen receptor T cell therapies have efficacy and have recently been approved by the US Food and Drug Administration (FDA) for the treatment of patients with acute leukemia. The Society for Immunotherapy of Cancer (SITC) convened a panel of experts to develop a clinical practice guideline composed of consensus recommendations on immunotherapy for the treatment of acute lymphoblastic leukemia and acute myeloid leukemia. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Keywords: immunotherapy; guidelines as topic; antineoplastic protocols; receptors; chimeric antigen; hematological neoplasms
Journal Title: Journal for ImmunoTherapy of Cancer
Volume: 8
Issue: 2
ISSN: 2051-1426
Publisher: Biomed Central Ltd  
Date Published: 2020-07-01
Start Page: e000810
Language: English
DOI: 10.1136/jitc-2020-000810
PUBMED: 33077513
PROVIDER: scopus
PMCID: PMC7574947
DOI/URL:

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85093910695&doi=10.1136%2fjitc-2020-000810&partnerID=40&md5=e1dd4e937ebd100276b43d236c1a15e6
Notes: Article -- Export Date: 2 November 2020 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Renier J Brentjens
    286 Brentjens
  2. Martin Stuart Tallman
    649 Tallman
Related MSK Work